Prevalence of parkin gene mutations and variations in idiopathic Parkinson's disease
- PMID: 16019250
- DOI: 10.1016/j.parkreldis.2005.04.003
Prevalence of parkin gene mutations and variations in idiopathic Parkinson's disease
Abstract
Mutations in the parkin gene are a common cause of autosomal recessive juvenile parkinsonism (AR-JP) but their role in idiopathic Parkinson's disease (PD) is not clear. Recent studies demonstrate that most young onset PD without family history is not due to mutations in parkin. However, there is less information about the role of this gene in older onset PD. The objective of the present study was to evaluate the prevalence and frequency of parkin gene mutations and variations in the general population of patients with PD categorized on the basis of family history and age of onset. We sequenced a sample of 50 familial PD patients, screened a sample of 429 PD patients, and 115 normal controls for the previously reported mutations, deletions, single nucleotide polymorphisms (SNP) in exons 2-12 of the parkin gene, and performed RT-PCR of exon 1. A total of two heterozygous mutations in exon 7 (R275W; 0.2%) were detected in the PD group, but none were found in controls. No mutation or deletion was observed in exons 2, 3, 5, 6, 8, 9 or 12. There was also no deletion or duplication of exon 1. The SNPs in exon 4, 10, and 11 that cause amino acid changes were very rare (1-5%). We did not find the exon 4 variation in the controls while allele frequencies were similar among PD patients and controls in exon 10 and 11 polymorphisms. Mutations were not associated with a positive family history of PD or younger age of onset. We concluded that no new mutation, nor the previously described parkin polymorphisms or known mutations, are playing any direct role in the development of PD in this group of PD patients.
Similar articles
-
A wide variety of mutations in the parkin gene are responsible for autosomal recessive parkinsonism in Europe. French Parkinson's Disease Genetics Study Group and the European Consortium on Genetic Susceptibility in Parkinson's Disease.Hum Mol Genet. 1999 Apr;8(4):567-74. doi: 10.1093/hmg/8.4.567. Hum Mol Genet. 1999. PMID: 10072423
-
Case-control study of the parkin gene in early-onset Parkinson disease.Arch Neurol. 2006 Apr;63(4):548-52. doi: 10.1001/archneur.63.4.548. Arch Neurol. 2006. PMID: 16606767
-
Parkin polymorphisms and environmental exposure: decrease in age at onset of Parkinson's disease.Neurotoxicology. 2007 May;28(3):698-701. doi: 10.1016/j.neuro.2007.01.004. Epub 2007 Jan 20. Neurotoxicology. 2007. PMID: 17335904
-
[Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease].Rinsho Shinkeigaku. 2004 Apr-May;44(4-5):241-62. Rinsho Shinkeigaku. 2004. PMID: 15287506 Review. Japanese.
-
Distribution, type, and origin of Parkin mutations: review and case studies.Mov Disord. 2004 Oct;19(10):1146-57. doi: 10.1002/mds.20234. Mov Disord. 2004. PMID: 15390068 Review.
Cited by
-
Metabolic landscape uncovers remodeling of T cell immunity affected by fatty acid desaturase in Parkinson's disease at single-cell resolution.BMC Biol. 2025 Aug 6;23(1):245. doi: 10.1186/s12915-025-02358-w. BMC Biol. 2025. PMID: 40770323 Free PMC article.
-
Mutations in PRKN and SNCA Genes Important for the Progress of Parkinson's Disease.Curr Genomics. 2013 Dec;14(8):502-17. doi: 10.2174/1389202914666131210205839. Curr Genomics. 2013. PMID: 24532983 Free PMC article.
-
Analysis of PRKN Variants and Clinical Features in Polish Patients with Parkinson's Disease.Curr Genomics. 2015 Aug;16(4):215-23. doi: 10.2174/1389202916666150326002549. Curr Genomics. 2015. PMID: 27006626 Free PMC article.
-
Effective quantitative real-time polymerase chain reaction analysis of the parkin gene (PARK2) exon 1-12 dosage.BMC Med Genet. 2007 Feb 26;8:6. doi: 10.1186/1471-2350-8-6. BMC Med Genet. 2007. PMID: 17324265 Free PMC article.
-
Variable PARK2 Mutations Cause Early-Onset Parkinson's Disease in a Small Restricted Population.J Mol Neurosci. 2017 Oct;63(2):216-222. doi: 10.1007/s12031-017-0972-3. Epub 2017 Sep 15. J Mol Neurosci. 2017. PMID: 28913705
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials